We use cookies to ensure that we give you the best experience on our website Learn more

Feb 18, 2019

12th International Conference on Advanced Technologies & Treatments for Diabetes

01 - METABOLIC BENEFITS AND DIABETES-RELATED DISTRESS WITH CONTINUOUS GLUCOSE MONITORING USE IN ELDERLY TYPE 1 AND TYPE 2 DIABETES PATIENTS USING MULTIPLE DAILY INJECTIONS OF INSULIN

cgm

mdi

type 2 diabetes

type 1 diabetes

elderly

Abstract

Abstract

thumbnail

Keywords

cgm

mdi

type 2 diabetes

type 1 diabetes

elderly

Abstract

Objective: Different challenges in diabetes care arise depending on the patients' age. Understanding older adults' perceptions of technology is important to assist with introducing it to this population and maximizing the potential of devices that can improve glycaemic control and quality of life. The aim was to determine the effectiveness of continuous glucose monitoring (CGM) introduction in elderly multiple daily injections (MDI) users. Methods: 25 participants (mean age 67±6 years, HbA1c=7.1±0.7%, diabetes duration 33±15 years) with type 1 (n=14) and type 2 (n=11) diabetes; treated by basal bolus MDI were enrolled in the study. Use of a CGM device in blinded mode was subsequently followed by real-time CGM. CGM data were analysed to determine glycaemic control parameters, diabetes-related emotional distress was measured by validated questionnaires. Differences were assessed with paired samples T-test; results were reported as mean± SD. Results: Significant improvements in time spent in target range (TIR= 4.4 - 7.2 mmol/L) (34.8±14.4% vs. 42.2±12.7%; p<0.05) and in hypoglycaemia (TIH) (13.5±12.2% vs 8.5±6.3%; p<0.05) as well as reduced glycaemic variability expressed by glycaemic variation (CV) (37.3±11.1% vs. 32.9±6.3%; p<0.05) were observed. Patients expressed overall positive experience with new technology introduction, that did not add to diabetes related distress (measured by Problem Areas in Diabetes Questionnaire). Majority of included elderly were eager to adopt new diabetes technology. Conclusion: Introduction of CGM use in well controlled elderly with long standing diabetes results in significant clinical benefit in glucose control (improved TIR, TIH and CV) without imposing an additional diabetes treatment related emotional burden.

Discover over 20,000 new abstracts, posters and presentations from leading academic conferences every month. Stay on top of the latest findings, methodologies and discussions happening in your research field around the world.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.